1. Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial. Issue 11 (21st November 2022) Authors: Trouiller, Jean-Baptiste; Macabeo, Bérengère; Poll, Andrew; Howard, Dan; Buckland, Andy; Sivignon, Marine; Clay, Emilie; Malka, David; Samalin, Emmanuelle; Toumi, Mondher; Laramée, Philippe Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗